Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear

Journal of Clinical Oncology

Volumn 16, Issue 6, 1998, Pages 2238-2245

  Wisman, G B ^a   Hollema, H ^a   De Jong, S ^a   Ter Schegget, J ^a   Tjong A Hung, S P ^a   Ruiters, M H ^a   Krans, M ^a   De Vries, E G ^a   Van Der Zee, A G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FROZEN SECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS TYPING; WART VIRUS;

EID: 0031749535     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.6.2238     Document Type: Article

References (42)

1. Herrero R: Epidemiology of cervical cancer. Monogr Natl Cancer Inst 21:1-6, 1996
2. Park T-W, Fujiwara H, Wright TC: Molecular biology of cervical cancer and its precursors. Cancer 76:1902-1913, 1995
3. Mitchell MF, Tortolero-Luna G, Wright T, et al: Cervical human papillomavirus infection and intraepithelial neoplasia: A review. Monogr Natl Cancer Inst 21:17-25, 1996
4. Herbert A: Is cervical screening working? Hum Pathol 28:120-126, 1997
5. Cox JT: Clinical role of HPV testing. Obstet Gynecol Clin North Am 23:811-851, 1996
6. Cuzick J, Szarewski A, Terry G, et al: Human papillomavirus testing in primary cervical screening. Lancet 345:1533-1536, 1995
7. Kaufman RH, Adam E, Icenogle J, et al: Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 176:87-92, 1997
8. Burger MPM, Hollema H, Pieters WJLM, et al: Predictive value of human papillomavirus type for histological diagnosis of women with cervical cytological abnormalities. Br Med J 310:94-95, 1995
9. Greider CW, Blackburn EH: Telomeres, telomerase and cancer. Sci Am 274:92-97, 1996
10. Rhyu MS: Telomeres, telomerase, and immortality. J Natl Cancer Inst 87:884-894, 1995
11. Klingelhutz AJ, Barber SA, Smith PP, et al: Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol 14:961-969, 1994
12. Klingelhutz AJ, Foster SA, McDougall JK: Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79-81, 1996
13. Kyo S, Kanaya T, Ishikawa H, et al: Telomerase activity in gynecological tumors. Clin Cancer Res 2:2023-2028, 1996
14. Zheng P-S, Iwasaka T, Yamasaki F, et al: Telomerase activity in gynecologic tumors. Gynecol Oncol 64:171-175, 1997
15. Pao CC, Tseng C-J, Lin C-Y, et al: Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial lesions. J Clin Oncol 15:1932-1937, 1997
16. Kyo S, Takakura M, Ishikawa H, et al: Application of telomerase assay for the screening of cervical lesions. Cancer Res 57:1863-1867, 1997
17. Gorham H, Yoshida K, Sugino T, et al: Telomerase activity in human gynaecological malignancies. J Clin Pathol 50:501-504, 1997
18. Zheng P-S, Iwasaka T, Yokoyama M, et al: Telomerase activation in in vitro and in vivo cervical carcinogenesis. Gynecol Oncol 66:222-226, 1997
19. Remmink AJ, Walboomers JM, Helmerhorst TJ, et al: The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Im J Cancer 61:306-311, 1995
20. Burger MPM, Hollema H, Gouw ASH, et al: Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. Br Med J 306:749-752, 1993
21. Hatch KD: Cervical cancer, in Berek JS, Hacker NF (eds): Practical Gynecologic Oncology (ed 2). Baltimore, MD, Williams & Wilkins, 1994, pp 243-283
22. Poulsen H: Grading of Cervical Cancer. Geneva, Switzerland, World Health Organization, 1973
23. Zijlstra JG, de Vries EGE, Mulder NH: Multifactorial drug resistance in an Adriamycin-resistant human small cell lung cancer cell line. Cancer Res 47:1780-1784, 1987
24. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the folin-phenol reagent. J Biol Chem 193:265-275, 1951
25. Kim NW, Piatyszak MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2014, 1994
26. Wright WE, Shay JW, Piatyszek MA: Modifications of a telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity, and sensitivity. Nucleic Acids Res 23:3794-3795. 1995
27. Boom R, Sol CJA, Salimans MMM, et al: Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28:495-503, 1990
28. Smits HL, Tieben LM, Tjong-A-Hung SP, et al: Detection and typing of human papillomaviruses present in fixed and stained archival cervical smears by a consensus polymerase chain reaction and direct sequencing allow the identification of a broad spectrum of human Papillomavirus types. J Gen Virol 73:3263-3268, 1992
29. Tieben LM, ter Schegget J, Minnaar RP: Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 42:265-280, 1993
30. Bornstein J, Rahat MA, Abramovici H: Etiology of cervical cancer: Current concepts. Obstet Gynecol Surv 50:146-154, 1995
31. Sharma HW, Sokoloski JA, Perez JR, et al: Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 92:12343-12346, 1995
32. Califano J, Ahrendt SA, Meininger G, et al: Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res 56:5720-5722, 1996
33. Yoshida K, Sugino T, Tahara H, et al: Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 79:362-369, 1997
34. Muller M, Heine B, Heicappell R, et al: Telomerase activity in bladder cancer, bladder washings and in urine. Int J Oncol 9:1169-1173, 1996
35. Yoshida K, Sugino T, Goodison S, et al: Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer 75:548-553, 1997
36. Hanselaar AGJM, Vooijs GP, Oud PS, et al: DNA ploidy patterns in cervical intraepithelial neoplasia grade 111 with and without synchronous invasive squamous cell carcinoma. Cancer 62:2537-2545, 1988
37. Ohyashiki K, Ohyashiki JH, Nishimaki J, et al: Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 57:2100-2010, 1997
38. Yashima K, Litzky LA, Kaiser L, et al: Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 57:2373-2377, 1997
39. Soder AI, Hoare SF, Muir S, et al: Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 14:1013-1021, 1997
40. Anderson S, Shera K, Ihle J, et al: Telomerase activation in cervical cancer. Am J Pathol 151:25-31, 1997
41. Breslow RA, Shay JW, Gazdar AF, et al: Telomerase and early detection of cancer. J Natl Cancer Inst 89:618-623, 1997
42. De Gruijl TD, Bontkes HJ, Walboomers JMM, et al: Immunoglobulin G responses against human papilloma type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J Natl Cancer Inst 89:630-638, 1997